Synthetic Biology: Gene Editing's Role in Diagnostics - Andrew Ellington - IEEE EMBS at NIH, 2019
Andrew Ellington, University of Texas Austin, gears his talk toward low-tech and biotech, reviewing what the miniaturization of qPCR devices offers versus genetics data sampling demands and requirements. Ellington investigates use case scenarios in gene editing and how collaboration with local entrepreneurs both assists communities and forwards technical development.
Read more about this event at hipt.embs.org/2019
Andrew Ellington, University of Texas Austin, gears his talk toward low-tech and biotech, reviewing what the miniaturization of qPCR devices offers versus genetics data sampling demands and requirements.